News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Prostate cancer spit test could save the NHS £500 million a year
Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, thanks to a new spit test which can be taken at home.
Multi-million-pound UK-wide platform into cancer immunotherapy launches
A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to discover why at least half of all patients fail to respond to immunotherapy or suffer from debilitating side effects.
Personalised radiotherapy for people with bladder cancer shows promise
Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder cancer.
New genetic testing pathways could ensure patients get personalised treatments and help to catch more BRCA-linked cancer cases
Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment and boost the number of people who get tested.
Dave Day raises more than £63,000 for The Institute of Cancer Research
A charity fundraising event that was set up as a tribute to Dave Myers, the much-loved TV chef, raised an incredible £63,169.32 for The Institute of Cancer Research, London.
Pioneering research technician apprenticeship programme wins major award
A pioneering apprenticeship programme at the ICR for aspiring laboratory research technicians has won the Education and Training Award at the UK Pharma Industry Awards.
Large-scale study confirms well-established cancer risk factors and identifies new ones
Researchers have examined thousands of genetically defined traits to identify possible causal relationships for eight common cancers.
New biological findings open the door to improved outcomes for young adults with sarcoma
A new study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumours have lagged behind those for their paediatric and older adult counterparts.
ICR among best UK universities for commercialisation, partnerships and engaging with the public
Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in the Knowledge Exchange Framework (KEF).
Breast and ovarian cancer linked to thousands of new gene variants
New research identifies specific genetic changes that can increase someone's risk of breast and ovarian cancers, to help guide clinical decision-making
ESMO 2024: More than half of advanced melanoma patients treated with combination immunotherapy survive the disease for at least 10 years
More than half of people diagnosed with advanced melanoma are now surviving the disease for ten years or more when they receive a combination immunotherapy treatment, according to a study led by researchers from the ICR and The Royal Marsden.
New drug target discovered for aggressive form of prostate cancer
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease – it could be a new target for treatment and used to help predict who will become resistant to hormone therapy.
